TRP_1170x120_12-19-19

2020

Law promises big O-T-C savings

Law promises big O-T-C savings

NEW YORK — A provision in the Coronavirus Aid, Relief and Economic Security (CARES) Act, which Congress passed and President Trump signed into law in March, offers a potential boon to consumers and retailers, according to Glaxo­Smith­Kline (GSK), which is one of the largest providers of over-the-counter medications in the world. The provision in the

CVS offers back-to-school self-care

CVS offers back-to-school self-care

WOONSOCKET, R.I. — CVS Pharmacy has rolled out back-to-school offerings focusing on strengthening immunity and instilling confidence in children, teens and parents. Whether students are heading back to school with increased safety measures, returning to video-based distance learning or anything in between, implementing new routines can be difficult. As families adjust, CVS is offering all

Anderson’s leadership elevates industry

Anderson’s leadership elevates industry

Steve Anderson knows a thing or two about leadership, having worked for both a congressman and, during his student days, a member of the British Parliament; run for the House of Representatives; and headed three major trade associations, currently as president and chief executive officer of the National Association of Chain Drug Stores. Recently he

Pandemic can’t slow Canadian drug chains’ momentum

Pandemic can’t slow Canadian drug chains’ momentum

TORONTO — Today, the Canadian over-the-counter and prescription drug business has grown to well over $55 billion (Canadian) and is heavily regulated. This sector has also benefited from the fact that pharmaceuticals currently comprise the second-largest health expenditure category in the country. The retail market offers a wide range of prescription and O-T-C medications, health

Buyers must act now to be ready for more demand surges

Buyers must act now to be ready for more demand surges

Over the last few months, retailers of all types have battle-tested their supply chains as they’ve worked to find ways to get critical products into their customers’ hands. In particular, the pharmacy sector has been hard hit, with shopper behavior vacillating between stockpiling and regular buying. This pattern shift has caused headaches for category buyers

How drug stores can remain a leading beauty destination

How drug stores can remain a leading beauty destination

Beauty and personal care consumers are leaving their pre-pandemic shopping mentalities behind as they return to stores with a reprioritized sense of self-care. State-wide shelter-in-place mandates pushed millions of Americans into their homes, fueling a reliance on grocery, convenience and drug store retailers to fulfill in-store beauty and wellness product needs. As a result, consumers’

‘Everyone needs to feel their job makes a difference’

‘Everyone needs to feel their job makes a difference’

As Charles Dickens once wrote, ‘It was the best of times, it was the worst of times.’ Retail pharmacy chains like CVS have seen their profits surge during the pandemic. As an essential industry, retail pharmacies were able to keep operating, even as many other retailers were forced to temporarily shutter. Employees at these pharmacies

Focus on items that shoppers will want post lockdown

Focus on items that shoppers will want post lockdown

The coronavirus crisis has changed how shoppers conduct their typical routines and engage with retailers, with many of them switching to new brands or shifting to online only. As we start to emerge from lockdowns and prepare for the next recovery phase, retail pharmacies will be tasked with identifying ways to get consumers to return

Shifts in health care product shopping will endure

Shifts in health care product shopping will endure

  Consumer health witnessed its slowest growth over the last five years, at 1.5% in 2019, according to Euromonitor International. The growth of both O-T-C and vitamins and dietary supplements (VDS), which account for more than 85% value sales of consumer health, was slow, leaving the industry with weak growth. A large part of the

It’s time to step up chain drug’s skin care and beauty game

It’s time to step up chain drug’s skin care and beauty game

I usually don’t mince words, but it is getting more and more challenging to write these opinion pieces with confidence. The difficulty is the two-month lead time between when I hand in my opinion and when you, gentle readers, absorb what I have to say. Now, amid our nation’s reopening, we are experiencing COVID surges

The new question for retailers: ‘Are you tracking?’

The new question for retailers: ‘Are you tracking?’

Product transparency is fast-becoming an industry standard — across virtually every channel. This visibility throughout the supply chain supports consumer preferences for locally sourced and/or ethically produced product, and allows manufacturers and distributors to proactively update progression and status as well as minimize disruption and mitigate customer risk. As it relates to transparency across the

Chain drug’s challenge: Make operations synergistic

Chain drug’s challenge: Make operations synergistic

At the top of an organization, the leader (CEO or president) holds a unique responsibility: making the whole of the enterprise worth more than the sum of its parts. In chain pharmacy today, this is a particular challenge that requires customer-centric innovation in order to create outsized value. Consider the “parts” that comprise most modern-day

Shoppers have seen the future and are acting on it

Shoppers have seen the future and are acting on it

Never underestimate the strength of the American consumer. That was clear from the very early days of the COVID-19 pandemic. As our world imploded in a matter of weeks, and uncertainty around both health and economic issues roiled the country, consumers got on with it. It was evident in the first of our COVID-19 series